Filtros : "Coelho, Eduardo Barbosa" "ROCHA, ADRIANA" Removido: "ILANA, GABRIELA GIMENEZ FAUSTINO" Limpar

Filtros



Refine with date range


  • Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 31 ago. 2024.
    • APA

      Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
    • NLM

      Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1002/jcph.1745
    • Vancouver

      Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1002/jcph.1745
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP

    Subjects: CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUSINATO, Diego Alberto Ciscato et al. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 430-441, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.029. Acesso em: 31 ago. 2024.
    • APA

      Cusinato, D. A. C., Filgueira, G. C. de O., Rocha, A., Cintra, M. A. de C. T., Lanchote, V. L., & Coelho, E. B. (2019). LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, 164, 430-441. doi:10.1016/j.jpba.2018.10.029
    • NLM

      Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.029
    • Vancouver

      Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.029
  • Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Assunto: FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Adriana et al. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, v. 70, n. 1, p. 43-51, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2010.03649.x. Acesso em: 31 ago. 2024.
    • APA

      Rocha, A., Coelho, E. B., Sampaio, S. A., & Lanchote, V. L. (2010). Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, 70( 1), 43-51. doi:10.1111/j.1365-2125.2010.03649.x
    • NLM

      Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x
    • Vancouver

      Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x
  • Source: Abstracts. Conference titles: World Conference on Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP

    Assunto: FARMACOCINÉTICA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Adriana et al. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. 2008, Anais.. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 31 ago. 2024.
    • APA

      Rocha, A., Coelho, E. B., Sampaio, S. A., & Lanchote, V. L. (2008). Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. In Abstracts. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
    • NLM

      Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. Abstracts. 2008 ;[citado 2024 ago. 31 ]
    • Vancouver

      Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. Abstracts. 2008 ;[citado 2024 ago. 31 ]
  • Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Subjects: GASTROENTEROLOGIA, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Adriana et al. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, v. 64, n. 9, p. 901-906, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00228-008-0510-x. Acesso em: 31 ago. 2024.
    • APA

      Rocha, A., Coelho, E. B., Moussa, S. A. P., & Lanchote, V. L. (2008). Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, 64( 9), 901-906. doi:10.1007/s00228-008-0510-x
    • NLM

      Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s00228-008-0510-x
    • Vancouver

      Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1007/s00228-008-0510-x

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024